Cargando…
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
Misoprostol is reported to prevent non-steroidal anti-inflammatory drug (NSAID)-associated gastroduodenal complications. There is, however, limited information regarding the efficacy of DA-9601 in this context. We performed a comparative study on the relative efficacy of DA-9601 and misoprostol for...
Autores principales: | Lee, Oh Young, Kang, Dae-Hwan, Lee, Dong Ho, Chung, Il-Kwun, Jang, Jae-Young, Kim, Jin-Il, Cho, Jin-Woong, Rew, Jong-Sun, Lee, Kang-Moon, Kim, Kyoung Oh, Choi, Myung-Gyu, Lee, Sang-Woo, Lee, Soo-Teik, Kim, Tae-Oh, Shin, Yong-Woon, Seol, Sang-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pharmaceutical Society of Korea
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176566/ https://www.ncbi.nlm.nih.gov/pubmed/24871787 http://dx.doi.org/10.1007/s12272-014-0408-3 |
Ejemplares similares
-
Erratum to: A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
por: Lee, Oh Young, et al.
Publicado: (2014) -
Prevention of NSAID-Associated Gastroduodenal Injury in Healthy Volunteers-A Randomized, Double-Blind, Multicenter Study Comparing DA-9601 with Misoprostol
por: Lee, Kang Nyeong, et al.
Publicado: (2011) -
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
por: Choi, Yoon Jin, et al.
Publicado: (2017) -
Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial—STORM STUDY
por: Park, Soo-Heon, et al.
Publicado: (2007) -
Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
por: Lee, Min-Taek, et al.
Publicado: (2020)